Mycoplasma pneumoniae - Targeted detection. Targeted treatment.

illumigene® Mycoplasma Direct provides highly accurate results in less than one hour from throat swabs and can be used as an aid in the diagnosis and treatment of Mycoplasma pneumoniae infections from the first day of symptoms.2

Targeted detection. Targeted treatment.

Improved test performance over traditional methods

  • Serology may have as low as 25% sensitivity1
  • X-Ray may have as low as 30% sensitivity3

Direct detection of active Mycoplasma pneumoniae infections

  • Single target test for increased clinical performance4

“One pathogen means better sensitivity and if a clinician is suspicious of Mycoplasma pneumoniae a single test should be used, panels are great for when clinicians need to go on fishing expeditions and cost is not a consideration.”

- Ken B. Waites, M.D., F(AAM)

Professor of Pathology; Director, Diagnostic Mycoplasma Laboratory, University of Alabama at Birmingham; Microbiology Consultant and Staff Pathologist, Birmingham Veterans Affairs Medical Center

New Molecular Test Now Available for Mycoplasma pneumoniae

illumigene® Mycoplasma Direct - Targeted detection from day one of symptoms so that appropriate antibiotics can be prescribed.
This email is sent to you by Meridian Bioscience, Inc., the market share leaders in Mycoplasma pneumoniae testing and the manufacturers of illumigene® - the only FDA-cleared molecular platform that offers standalone tests for the detection of Mycoplasma pneumoniae from throat swabs.

References
1. Nilsson A, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.BMC Microbiology 2008, 8:93. 2. illumigene® Mycoplasma Direct Package Insert, SN11194. 3. Graffelman, A. W., Willemssen, F. E., Zonderland, H. M., et al. Limited value of chest radiography in predicting aetiology of lower respiratory tract infection in general practice. The British Journal of General Practice, 58.547 (2008): 93–97. 4. Chou, R. C., & Zheng, X. A comparison of molecular assays for Mycoplasma pneumoniae in pediatric patients. Diagnostic Microbiology and Infectious Disease 85(2016), 6-8.